Potential Applications of Calocybe indica Ethanol Extract in Noniceptive and Neuronal Pain
DOI:
https://doi.org/10.61841/9d6e1885Keywords:
Calocybe Indica, Analgesic Potential, CNS Activity, Membrane Stabilizing ActivityAbstract
Calocybe indica belonging to the family Lyophyllaceae, Analgesic potential, CNS test and membrane stabilizing activity of Calocy be indicaethanolicextract (ETCL) were evaluated by some different standard methods. The results of the study showed that ETCI possess peripherally and centrally acting analgesic potential in mice model. In acetic acid induced writhing method, ETCI (100mg/kg & 150mg/kg) significantly (P<0.001, P˂0.05) reduced pain sensation with 71.62% & 54.59% inhibition as compared to standard with 82.96% of inhibition respectively. In hot plate method 100mg/kg ETCI increased reaction time with 13.12%,12.90% &19.40% of latency compare to standard (14.70%, 7.24% & 2.77%) at 0min and 60 min respectively which is statistically significant (p<0.001, P˂0.05). Again ETCI (150mg/kg) increased reaction time (8.19%, 15.09% and 19.79%) which is statistically significant (p<0.001, P˂0.05) at 0min to 60min. In open field method ETCI showed sedative effect (100mg/kg,150mg/kg) at 0min & 60 min which is statistically significant (p<0.001, P˂0.05) but not dose depending manner. In hole cross method ETCI (100mg/kg, 150mg/kg) also showed significant (p<0.001, P˂0.05) sedative effect at 0min & 60 min. The ETCI were effective in membrane stabilizing activity as the extractives prevented the lyses of erythrocytes induced by hypotonic solution. During hypotonic condition the different doses of ETCI (100 &150mg/kg) showed lyses inhibition 65.27% & 10.51% respectively compared to standard with 56.65% of inhibition. The 100mg/kg dose of ETCI had showed the better result than 150mg/kg in membrane stabilizing activity. The investigations revealed that the ethanolic extracts of ETCI possess both central and peripheral analgesic potentials and also have sedative effect with membrane stabilizing activity.
Downloads
References
1. Kumar K. Role of edible mushrooms as functional foods—a review. South Asian Journal of Food Technology and Environment. 2015;1(3&4):211-8.
2. Amit R, Pushpa P. Properties and uses of an indigenous mushroom: Calocybe indica. Asian Journal of Pharmacy and Technology. 2014;4(1).
3. Reis FS, Barros L, Martins A, Ferreira IC. Chemical composition and nutritional value of the most widely appreciated cultivated mushrooms: an inter-species comparative study. Food and Chemical Toxicology. 2012 Feb 1;50(2):191-7.
4. Wani BA, Bodha RH, Wani AH. Nutritional and medicinal importance of mushrooms. Journal of Medicinal Plants Research. 2010 Dec 18;4(24):2598-604.
5. Yilmaz N, Solmaz M, Türkekul İ, Elmastaş M. Fatty acid composition in some wild edible mushrooms growing in the middle Black Sea region of Turkey. Food Chemistry. 2006 Jan 1;99(1):168-74.
6. Pushpa H, Purushothoma KB. Nutritional analysis of wild and cultivated edible medicinal mushrooms. World Journal of Diary and Food Sciences. 2010; 5:140-4.
7. Saranya V, Madhanraj P, Panneerselvam A. Cultivation, composting, biochemical and molecular characterization of Calocybe indica (C and A). Asian Journal of Pharmaceutical Research. 2011;1(3):55-7.
8. Mattila P, Suonpää K, Piironen V. Functional properties of edible mushrooms. Nutrition (Burbank, Los Angeles County, Calif.). 2000;16(7-8):694-6.
9. Dikeman CL, Bauer LL, Flickinger EA, Fahey GC. Effects of stage of maturity and cooking on the chemical composition of select mushroom varieties. Journal of agricultural and food chemistry. 2005 Feb 23;53(4):1130-8.
10. Periasamy K. Novel antibacterial compounds obtained from some edible mushrooms. International Journal of Medicinal Mushrooms. 2005;7(3).
11. Lelley J, Vetter J. The possible role of mushrooms in maintaining good health and preventing diseases. In Proceedings of the Fifth International Conference on Mushroom Biology and Mushroom Products. Shanghai Academy of Agricultural Sciences, Shanghai, China 2005 Apr (pp. 412-419).
12. Shah S, Ghosh D, Mallick SK, Sarangi I, Bhutia SK, Banerje I, Maiti S, Maiti TK. Immunomodulatory and antitumor activities of water-soluble proteoglycan isolated from the fruiting bodies of culinary-medicinal oyster mushroom Pleurotusostreatus (Jacq.: Fr.) P. Kumm.(agaricomycetideae). International Journal of Medicinal Mushrooms. 2007;9(2).
13. Wani BA, Bodha RH, Wani AH. Nutritional and medicinal importance of mushrooms. Journal of Medicinal Plants Research. 2010 Dec 18;4(24):2598-604.
14. Selvi S, Umadevi P, Murugan S, Senapathy JG. Anticancer potential evoked by Pleurotusflorida and Calocybe indica using T 24 urinary bladder cancer cell line. African Journal of Biotechnology. 2011;10(37):7279-85.
15. Feng W. A Clinical Pilot Study of EEM for Advanced Cancer-Treatment with EEM for Improvement of Cachexia and Immune Function Compared with MPA. BIOTHERAPY-TOKYO-. 2001;15(6):691-6.
16. Williamson EM, Okpako DT, Evans FJ. Selection, preparation and pharmacological evaluation of plant material. John Wiley & Sons; 1996 Jul 10.
17. Amabeoku GJ, Kabatende J. Antinociceptive and anti-inflammatory activities of leaf methanol extract of Cotyledon orbiculata L.(Crassulaceae). Advances in pharmacological sciences. 2012;2012.
18. Koster R. Acetic acid for analgesic screening. InFed proc 1959 (Vol. 18, p. 412).
19. Munira MS, Islam MS, Baharuddin M, Koly SF. In vivo CNS Activity of Methanolic Extract of Ficusracemosa Fruits in Experimental Animals. Bangladesh Pharmaceutical Journal. 2018 Aug 15;21(2):139-44.
20. Takagi K, WATANABE M, SAITO H. Studies of the spontaneous movement of animals by the hole cross test; effect of 2-dimethyl-aminoethanol and its acyl esters on the central nervous system. The Japanese Journal of Pharmacology. 1971;21(6):797-810.
21. Sadique J, Al-Rqobahs WA, Bughaith EI, Gindi AR. The bioactivity of certain medicinal plants on the stabilization of RBC membrane system. Fitoterapia. 1989;60(6):525-32.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
